ENDOCRINE DISRUPTING CHEMICALS-INDUCED METABOLIC DISORDERS AND TREATMENT STRATEGIES

ENDOCRINE DISRUPTING CHEMICALS-INDUCED METABOLIC DISORDERS AND TREATMENT STRATEGIES

Editorial:
SPRINGER
Año de edición:
Materia
Medicina Interna
ISBN:
978-3-030-45922-2
Páginas:
520
N. de edición:
1
Idioma:
Inglés
Ilustraciones:
176
Disponibilidad:
Disponible en 2-3 semanas

Descuento:

-5%

Antes:

124,80 €

Despues:

118,56 €

• Part I: Introduction to endocrine system and metabolic disorders. - Chapter 1: Physiology of endocrine system and related metabolic disorders
Chapter 2: Impaired carbohydrate metabolism in metabolic disorders
Chapter 3: Mitochondrial dysfunction in metabolic disorders
Chapter 4: Inherited metabolic disorders-a current status
Chapter 5: Impaired lipid metabolism in metabolic disorders
Chapter 6: Impaired thyroid function in metabolic disorders.
• Part II: Role of endocrine disrupting chemicals in metabolic disorders
Chapter 7: Endocrine-disrupting chemicals: Occurrence and exposure to the human being
Chapter 8: Antibiotic resistance in EDCs-induced metabolic disorders
Chapter 9: Alteration of gut microbiota in EDCs-induced metabolic disorders
Chapter 10: Endocrine disrupting chemicals induced childhood obesity
Chapter 11: Role of polychlorinated biphenyls as EDCs in metabolic disorders
Chapter 12: Role of furans as EDCs in metabolic disorders
Chapter 13: Role of heavy metals in metabolic disorders
Chapter 14: Role of flame-retardants as EDCs in metabolic disorders
Chapter 15: Role of phthalates as EDCs in metabolic disorders. - Chapter 16: Bisphenol A as an EDC in metabolic disorders
Chapter 17: Role of pesticides as EDCs in metabolic disorders
Chapter 18: Role of perfluoroalkyl substances as EDCs in metabolic disorders
Chapter 19: Role of polycyclic aromatic hydrocarbons as EDCs in metabolic disorders
Chapter 20: Tobacco smoking as an EDC in metabolic disorders
Chapter 21: Role of pharmaceuticals as EDCs in metabolic disorders
Chapter 22: Parabens as endocrine disrupting chemicals and their association with metabolic disorders
Chapter 23: Role of aflatoxins as EDCs in metabolic disorders
• Part III: Treatment strategies of EDCs-induced metabolic disorders: From prevention to intervention
Chapter 24: Hormone harmony in metabolic disorders
Chapter 25: Role of nanoparticles in the management of metabolic disorders
Chapter 26: Intermittent fasting for treatment of metabolic disorders
Chapter 27: rbs and spices as natural medicine for treatment of metabolic disorders
Chapter 28: Bioactive compounds for the treatment of metabolic disorders.

This volume offers a detailed and comprehensive analysis of Endocrine Disrupting Chemicals (EDCs), covering their occurrence, exposure to humans and the mechanisms that lead to the parthogenesisof EDCs-induced metabolic disorders. The book is divided into three parts. Part Idescribes the physiology of the human endocrine system, with special emphasis on various types of metabolic disorders along with risk factors that are responsible for the development of these disorders. Part II addresses all aspects of EDCs, includingtheir role in the induction of various risk factors that are responsible for the development of metabolic disorders. Part III covers up-to-date environmental regulatory considerations andtreatment strategies that have been adopted to cure and prevent EDCs-induced metabolic disorders. This section will primarily appeal toclinicians investigating the causes and treatment of metabolic disorders. The text will also be of interest to students and researchers in thefields of Environmental Pharmacology and Toxicology, Environmental Pollution, Pharmaceutical Biochemistry, Biotechnology, and Drug Metabolism/Pharmacokinetics.

Features
• Offers a comprehensive analysis of EDCs from their occurrence to induced metabolic disorders in humans
• Provides detailed information to researchers and clinicians investigating metabolic disorders
• Discusses treatment strategies and regulatory considerations of EDCs-induced metabolic disorders